Filter
566
Text search:
Pharmaceutical
Assessment
Featured
Recommendations
54
New Publications
127
Language
Document type
No document type
280
Studies & Reports
119
Guidelines
90
Strategic & Response Plan
28
Manuals
22
Fact sheets
10
Training Material
6
Situation Updates
4
Resource Platforms
4
Brochures
3
Countries / Regions
Ethiopia
28
Kenya
24
India
23
Global
21
Western and Central Europe
17
South Africa
16
Nigeria
13
Ghana
12
Rwanda
12
Uganda
11
Malawi
10
Zambia
9
Eastern Europe
9
Sierra Leone
8
Liberia
8
Zimbabwe
8
Tanzania
8
Nepal
7
Africa
7
Syria
6
Namibia
6
Senegal
5
Philippines
5
Ukraine
4
Cameroon
3
Bangladesh
3
Eswatini/ Swaziland
3
South–East Asia Region
3
Venezuela
3
South Sudan
2
Sudan
2
Benin
2
Botswana
2
Lesotho
2
West and Central Africa
2
Albania
2
Burkina Faso
1
Congo, Democratic Republic of
1
Mali
1
Niger
1
Pakistan
1
Jordan
1
Chad
1
Cambodia
1
Indonesia
1
Mozambique
1
Papua New Guinea
1
Brazil
1
North Macedonia
1
Chile
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Asia
1
Timor Leste/ East Timor
1
Russia
1
Lithuania
1
Vietnam
1
Gabon
1
Denmark
1
France
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
245
Clinical Guidelines
38
Key Resources
37
Public Health
27
Women & Child Health
14
Pharmacy & Technologies
9
Capacity Building
3
Annual Report MEDBOX
1
Toolboxes
COVID-19
62
AMR
55
Pharmacy
44
Mental Health
30
TB
28
HIV
24
NTDs
17
NCDs
14
Rapid Response
13
Caregiver
11
Conflict
10
Planetary Health
10
Disability
8
Global Health Education
7
Ebola & Marburg
6
Specific Hazards
5
Health Financing Toolbox
4
2.0 Rapid Response
3
Natural Hazards
2
Refugee
2
Malaria
2
Cholera
1
Polio
1
Zika
1
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
The power relations around global decisions which shape population health can be changed through new alliances and information flows. The Democratising Global Health Governance Initiative, of which WHO Watch is a project, is designed to contribute to improved population health (and health equity) th
...
WHO Secretariat Information paper July 2016
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
Guidelines for social mobilization
TB and poverty; TB and children; TB and women; TB, migrants and refugees; TB and prisons
WHO/CDS/STB/2001.9
Original: English; Distribution: Limited
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: Drug-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdd
...
In an environment of stagnant donor funding and increasing private sector investment in low- and middle-income countries, actors in both the public and private sectors are increasingly interested in using blended finance approaches to catalyze new funding for global health and achieve health outcome
...
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ
...